PAI
PFE icon

Pittenger & Anderson Inc’s Pfizer PFE Stock Holding History

Pittenger & Anderson Inc’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-150
Closed -$3.73K – 553
2025
Q4 		$3.73K Hold
150
– – ﹤0.01% 454
2025
Q3 		$3.82K Sell
150
-110,185
-100% -$2.72M ﹤0.01% 408
2025
Q2 		$2.67M Sell
110,335
-5,666
-5% -$132K 0.1% 134
2025
Q1 		$2.94M Buy
116,001
+13,481
+13% +$353K 0.11% 131
2024
Q4 		$2.72M Buy
102,520
+101,460
+9,572% +$2.75M 0.1% 136
2024
Q3 		$30.7K Buy
1,060
+150
+16% +$4.38K ﹤0.01% 324
2024
Q2 		$25.5K Hold
910
– – ﹤0.01% 323
2024
Q1 		$25.3K Sell
910
-975
-52% -$27.1K ﹤0.01% 324
2023
Q4 		$54.3K Hold
1,885
– – ﹤0.01% 283
2023
Q3 		$62.5K Sell
1,885
-25,412
-93% -$899K ﹤0.01% 267
2023
Q2 		$1M Sell
27,297
-78,795
-74% -$3.07M 0.05% 142
2023
Q1 		$4.33M Sell
106,092
-2,622
-2% -$113K 0.22% 105
2022
Q4 		$5.57M Sell
108,714
-479
-0.4% -$23K 0.31% 89
2022
Q3 		$4.78M Buy
109,193
+720
+0.7% +$35K 0.29% 91
2022
Q2 		$5.69M Buy
108,473
+204
+0.2% +$10.4K 0.33% 83
2022
Q1 		$5.61M Buy
108,269
+1,765
+2% +$91.6K 0.27% 93
2021
Q4 		$6.29M Buy
106,504
+6,700
+7% +$332K 0.29% 91
2021
Q3 		$4.29M Buy
99,804
+2,332
+2% +$103K 0.22% 103
2021
Q2 		$3.82M Buy
97,472
+1,580
+2% +$61.4K 0.2% 104
2021
Q1 		$3.47M Buy
95,892
+4,017
+4% +$143K 0.19% 109
2020
Q4 		$3.38M Sell
91,875
-3,196
-3% -$117K 0.19% 112
2020
Q3 		$3.31M Buy
95,071
+4,048
+4% +$142K 0.21% 104
2020
Q2 		$2.82M Sell
91,023
-4,715
-5% -$160K 0.2% 107
2020
Q1 		$2.96M Sell
95,738
-2,736
-3% -$93.2K 0.25% 96
2019
Q4 		$3.66M Buy
98,474
+544
+0.6% +$19.4K 0.24% 101
2019
Q3 		$3.34M Buy
97,930
+951
+1% +$34.6K 0.24% 104
2019
Q2 		$3.99M Buy
96,979
+896
+0.9% +$35.6K 0.3% 93
2019
Q1 		$3.87M Buy
96,083
+448
+0.5% +$17.9K 0.3% 92
2018
Q4 		$3.96M Buy
95,635
+606
+0.6% +$25.2K 0.36% 78
2018
Q3 		$3.97M Buy
95,029
+5,797
+6% +$223K 0.31% 98
2018
Q2 		$3.07M Sell
89,232
-184
-0.2% -$6.29K 0.26% 110
2018
Q1 		$3.01M Buy
89,416
+3,584
+4% +$123K 0.26% 107
2017
Q4 		$2.95M Buy
85,832
+6,281
+8% +$214K 0.26% 108
2017
Q3 		$2.69M Sell
79,551
-43,820
-36% -$1.41M 0.24% 107
2017
Q2 		$3.93M Sell
123,371
-1,851
-1% -$58.4K 0.38% 73
2017
Q1 		$4.06M Sell
125,222
-9,143
-7% -$288K 0.41% 65
2016
Q4 		$4.14M Sell
134,365
-100
-0.1% -$3.05K 0.44% 60
2016
Q3 		$4.32M Buy
134,465
+3,204
+2% +$107K 0.48% 54
2016
Q2 		$4.38M Buy
131,261
+69
+0.1% +$2.2K 0.48% 53
2016
Q1 		$3.69M Buy
131,192
+6,292
+5% +$180K 0.43% 65
2015
Q4 		$3.83M Buy
124,900
+5,523
+5% +$174K 0.48% 56
2015
Q3 		$3.56M Buy
119,377
+3,573
+3% +$115K 0.47% 55
2015
Q2 		$3.68M Buy
115,804
+3,536
+3% +$115K 0.47% 52
2015
Q1 		$3.71M Buy
112,268
+15,852
+16% +$504K 0.48% 49
2014
Q4 		$2.85M Buy
96,416
+3,305
+4% +$94.8K 0.38% 74
2014
Q3 		$2.61M Buy
93,111
+3,177
+4% +$89.2K 0.38% 66
2014
Q2 		$2.53M Buy
89,934
+9,049
+11% +$258K 0.37% 74
2014
Q1 		$2.46M Buy
80,885
+4,390
+6% +$131K 0.34% 79
2013
Q4 		$2.22M Buy
76,495
+6,903
+10% +$201K 0.31% 83
2013
Q3 		$1.9M Buy
69,592
+13,335
+24% +$363K 0.3% 90
2013
Q2 		$1.5M Buy
+56,257
New +$1.55M 0.26% 107

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Pittenger & Anderson Inc's PFE Position: Q1 2026 in Review

Pittenger & Anderson Inc sold out of Pfizer (PFE) in Q1 2026, closing a stake of 150 shares — an estimated $3.73K sold.

Pittenger & Anderson Inc first reported a position in PFE in Q2 2013 and held it in 51 quarters. The position peaked at $6.29M in Q4 2021. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Pittenger & Anderson Inc reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Pittenger & Anderson Inc sold 150 Pfizer shares in Q1 2026, an estimated $3.73K.
  • Pittenger & Anderson Inc first reported a position in Pfizer in Q2 2013 and held it in 51 quarters.
  • Pittenger & Anderson Inc's Pfizer position peaked at $6.29M in Q4 2021.
  • 2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Pittenger & Anderson Inc's 13F filing for Q1 2026, filed 1 May 2026.